管理抗结核药物引起的肝毒性:对方法的比较研究
Faeze Abbaspour1,2, Malihe Hasannezhad3, Hossein Khalili4
1School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Archives of Iranian medicine
|April 30, 2024
概括
结核病药物的肝毒性是常见的. 女性性别,病毒性肝炎,心脏病和肝酶升高是重新治疗失败的危险因素,但两种剂量策略显示了类似的结果.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 结核病 (TB) 仍然是一个全球性的健康挑战,需要有效的治疗.
- 抗结核病药物可能会导致肝毒性,导致停止治疗.
- 确定药物诱导的肝损伤的风险因素和最佳再治疗策略至关重要.
研究的目的:
- 确定管理抗结核药物诱导的肝毒性的方法.
- 调查与再治疗结果相关的人口和临床因素.
- 为了比较两种不同的抗结核病再治疗方案.
主要方法:
- 从2015年4月到2019年2月的医疗记录的回顾性审查.
- 通过针对抗结核病药物诱导的肝毒性患者的问卷收集的数据.
- 对重新治疗失败的风险因素的分析和两种剂量策略的比较.
主要成果:
- 女性性别,体重减轻,C型肝炎,乙型肝炎病毒 (HBV),心脏病和高AST/ALT水平是重新治疗失败的风险因素.
- 两种重新治疗方法 (渐进的全剂量与最低至最高剂量) 在控制肝毒性方面没有显著差异.
- 在肝毒性开始时肝酶 (AST,ALT) 的升高表明风险更高.
结论:
- 药物诱导的肝毒性是TB治疗中断的常见原因之一.
- 了解风险因素是改善患者治疗结果和降低死亡率的关键.
- 对结核病药物诱导的肝损伤的最佳再挑战策略进行进一步的研究是有必要的.
相关概念视频
Pulmonary Tuberculosis V
178
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
178
Pulmonary Tuberculosis I
241
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
241
Pulmonary Tuberculosis IV
140
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
140
Prevention of Further Absorption of Poison
817
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
817
Pulmonary Tuberculosis II
226
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
226
Hepatic Drug Excretion: Enterohepatic Cycling
1.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K


